• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score.COMPASS 31:改良和简化的综合自主症状评分。
Mayo Clin Proc. 2012 Dec;87(12):1196-201. doi: 10.1016/j.mayocp.2012.10.013.
2
Validation of the Composite Autonomic Symptom Score 31 in the German language.验证复合自主症状评分 31 量表的德语版本。
Neurol Sci. 2022 Jan;43(1):365-371. doi: 10.1007/s10072-021-05764-4. Epub 2021 Nov 25.
3
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms.自主神经症状概况:一种评估自主神经症状的新工具。
Neurology. 1999 Feb;52(3):523-8. doi: 10.1212/wnl.52.3.523.
4
Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire.采用 COMPASS-31 问卷评估系统性硬化症自主神经功能障碍的症状。
J Rheumatol. 2018 Aug;45(8):1145-1152. doi: 10.3899/jrheum.170868. Epub 2018 Jun 15.
5
Validation and reliability of the Turkish version of the composite autonomic symptom score 31.土耳其语版综合自主症状评分 31 的验证和可靠性。
Neurol Sci. 2024 Dec;45(12):5779-5786. doi: 10.1007/s10072-024-07776-2. Epub 2024 Sep 24.
6
Validation of the composite autonomic symptom scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy.复合自主神经症状量表31(COMPASS - 31)在有和无小纤维多发性神经病患者中的验证
Eur J Neurol. 2015 Jul;22(7):1124-30. doi: 10.1111/ene.12717. Epub 2015 Apr 23.
7
Translation and linguistic validation of the Composite Autonomic Symptom Score COMPASS 31.复合自主神经症状评分量表COMPASS 31的翻译及语言验证
Neurol Sci. 2015 Oct;36(10):1897-902. doi: 10.1007/s10072-015-2278-y. Epub 2015 Jun 17.
8
Translation and linguistic validation of the Composite Autonomic Symptom Score COMPASS 31 in Danish.丹麦文版综合自主症状评分 COMPASS 31 的翻译与语言验证。
Dan Med J. 2021 Feb 9;69(3):A07210576.
9
Clinical Assessment of Autonomic Function in Fibromyalgia by the Refined and Abbreviated Composite Autonomic Symptom Score (COMPASS 31): A Case-Controlled Study.通过改良简化综合自主症状评分(COMPASS 31)对纤维肌痛症自主功能的临床评估:病例对照研究。
Rev Recent Clin Trials. 2022;17(1):53-57. doi: 10.2174/1574887116666210612033002.
10
Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease.验证帕金森病患者复合自主症状量表 31 的韩文版。
PLoS One. 2021 Oct 21;16(10):e0258897. doi: 10.1371/journal.pone.0258897. eCollection 2021.

引用本文的文献

1
Autonomic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Findings from the Multi-Site Clinical Assessment of ME/CFS (MCAM) Study in the USA.肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)中的自主神经功能障碍:美国ME/CFS多中心临床评估(MCAM)研究的结果
J Clin Med. 2025 Sep 5;14(17):6269. doi: 10.3390/jcm14176269.
2
Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteria.遗传性转甲状腺素蛋白淀粉样变性的真实世界治疗管理——一份经验报告及治疗转换决策标准建议
Neurol Res Pract. 2025 Sep 12;7(1):65. doi: 10.1186/s42466-025-00428-6.
3
Cardiovascular autonomic failure correlates with cutaneous autonomic denervation in PD and MSA.心血管自主神经功能衰竭与帕金森病(PD)和多系统萎缩(MSA)中的皮肤自主神经去神经支配相关。
Clin Auton Res. 2025 Sep 12. doi: 10.1007/s10286-025-01154-4.
4
Fatigue, interoplastic and nociplastic distress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Illness, and chronic idiopathic fatigue.肌痛性脑脊髓炎/慢性疲劳综合征、海湾战争综合征及慢性特发性疲劳中的疲劳、间质性疼痛和神经源性疼痛困扰
Front Neurosci. 2025 Aug 25;19:1530652. doi: 10.3389/fnins.2025.1530652. eCollection 2025.
5
Structured Symptom Assessment to Identify Patients With Small Fiber or Autonomic Neuropathy in Fibromyalgia.用于识别纤维肌痛中小纤维或自主神经病变患者的结构化症状评估
Eur J Neurol. 2025 Sep;32(9):e70349. doi: 10.1111/ene.70349.
6
Characterization of Postural Orthostatic Tachycardia Syndrome in Long COVID: Self-reported Data From the LISTEN Study.长新冠患者体位性直立性心动过速综合征的特征:来自LISTEN研究的自我报告数据。
JACC Adv. 2025 Aug;4(8):101873. doi: 10.1016/j.jacadv.2025.101873.
7
Evaluation of Cardiac Autonomic Function in Patients Undergoing Thoracoscopic Sympathetic Chain Clamping for Primary Focal Hyperhidrosis.原发性局限性多汗症患者行胸腔镜交感神经链夹闭术时心脏自主神经功能的评估
Med Sci (Basel). 2025 Aug 20;13(3):147. doi: 10.3390/medsci13030147.
8
Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes.长期1型糖尿病患者冠状动脉粥样硬化和心肌功能障碍的风险及保护因素。
Diabetologia. 2025 Aug 20. doi: 10.1007/s00125-025-06521-4.
9
Glycaemic control, low levels of high-density lipoprotein, and high cardiovascular risk are associated with cardiovascular autonomic neuropathy.血糖控制不佳、高密度脂蛋白水平低以及心血管风险高与心血管自主神经病变相关。
Diabetol Metab Syndr. 2025 Aug 4;17(1):313. doi: 10.1186/s13098-025-01834-1.
10
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy.临床诊断为遗传性多发性神经病患者的临床及基因重新评估
Eur J Neurol. 2025 Aug;32(8):e70301. doi: 10.1111/ene.70301.

本文引用的文献

1
The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.直立性低血压问卷 (OHQ):一种新型症状评估量表的验证。
Clin Auton Res. 2012 Apr;22(2):79-90. doi: 10.1007/s10286-011-0146-2. Epub 2011 Nov 2.
2
Health-related quality of life in multiple system atrophy.多系统萎缩患者与健康相关的生活质量
Mov Disord. 2006 Jun;21(6):809-15. doi: 10.1002/mds.20808.
3
Depressive symptoms and life satisfaction in patients with multiple system atrophy.多系统萎缩患者的抑郁症状与生活满意度
Mov Disord. 2005 Aug;20(8):951-7. doi: 10.1002/mds.20450.
4
Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures.直立性低血压的评估:一种新型自我报告工具与基于实验室测量方法的关系。
Mayo Clin Proc. 2005 Mar;80(3):330-4. doi: 10.4065/80.3.330.
5
Autonomic symptoms and diabetic neuropathy: a population-based study.自主神经症状与糖尿病神经病变:一项基于人群的研究。
Diabetes Care. 2004 Dec;27(12):2942-7. doi: 10.2337/diacare.27.12.2942.
6
Autonomic dysfunction in dementia with Lewy bodies.路易体痴呆中的自主神经功能障碍。
Neurology. 2004 May 25;62(10):1804-9. doi: 10.1212/01.wnl.0000125192.69777.6d.
7
Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings.直立性心动过速综合征患者功能残疾的相关因素:初步横断面研究结果
Health Psychol. 2003 Nov;22(6):643-8. doi: 10.1037/0278-6133.22.6.643.
8
Quality of life in patients with postural tachycardia syndrome.体位性心动过速综合征患者的生活质量
Mayo Clin Proc. 2002 Jun;77(6):531-7. doi: 10.4065/77.6.531.
9
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms.自主神经症状概况:一种评估自主神经症状的新工具。
Neurology. 1999 Feb;52(3):523-8. doi: 10.1212/wnl.52.3.523.
10
Medications that may contribute to sexual disorders. A guide to assessment and treatment in family practice.可能导致性功能障碍的药物。家庭医疗中的评估与治疗指南。
J Fam Pract. 1997 Jan;44(1):33-43.

COMPASS 31:改良和简化的综合自主症状评分。

COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score.

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Mayo Clin Proc. 2012 Dec;87(12):1196-201. doi: 10.1016/j.mayocp.2012.10.013.

DOI:10.1016/j.mayocp.2012.10.013
PMID:23218087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3541923/
Abstract

OBJECTIVE

To develop a concise and statistically robust instrument to assess autonomic symptoms that provides clinically relevant scores of autonomic symptom severity based on the well-established 169-item Autonomic Symptom Profile (ASP) and its validated 84-question scoring instrument, the Composite Autonomic Symptom Score (COMPASS).

PATIENTS AND METHODS

We assessed the internal consistency of COMPASS using Cronbach α coefficients based on the ASP of 405 healthy control subjects recruited and seen in the Mayo Clinic Autonomic Disorders Center between March 1, 1995, and March 31, 2010. Applying a simplified scoring algorithm, we then used exploratory factor analysis with orthogonal rotation and eigenvalue calculations to extract internally consistent domains and to reduce dimensionality. This analysis was followed by expert revisions to eliminate redundant content and to retain clinically important questions and final assessment of the new instrument.

RESULTS

The new simplified scoring algorithm alone resulted in higher Cronbach α values in all domains. Factor analysis revealed 7 domains with a total of 54 questions retained. Expert revisions resulted in further reduction of questions and domains with a remaining total of 31 questions in 6 domains (COMPASS 31). Measures of internal consistency were much improved compared to those for COMPASS. Following appropriate weighting, this instrument provides an autonomic symptom score from 0 to 100.

CONCLUSION

COMPASS 31 is a refined, internally consistent, and markedly abbreviated quantitative measure of autonomic symptoms. It is based on the original ASP and COMPASS, applies a much simplified scoring algorithm, and is suitable for widespread use in autonomic research and practice.

摘要

目的

开发一种简洁且统计稳健的工具,以评估自主症状,根据经过验证的 169 项自主症状概况(ASP)及其经过验证的 84 项评分工具,即综合自主症状评分(COMPASS),提供具有临床相关性的自主症状严重程度评分。

患者和方法

我们评估了基于 Mayo 诊所自主障碍中心 1995 年 3 月 1 日至 2010 年 3 月 31 日招募和就诊的 405 名健康对照者的 ASP,使用 Cronbach α 系数评估 COMPASS 的内部一致性。应用简化的评分算法,我们随后使用正交旋转和特征值计算进行探索性因子分析,以提取内部一致的域并降低维度。然后,我们进行了专家修订以消除冗余内容并保留临床重要问题,最后评估新工具。

结果

简化评分算法本身导致所有域的 Cronbach α 值更高。因子分析显示保留了 7 个域和总共 54 个问题。专家修订进一步减少了问题和域,保留了总共 6 个域中的 31 个问题(COMPASS 31)。与 COMPASS 相比,内部一致性测量得到了很大改善。经过适当加权,该工具提供了 0 到 100 的自主症状评分。

结论

COMPASS 31 是一种经过改进的、内部一致的、明显简化的自主症状定量测量工具。它基于原始的 ASP 和 COMPASS,应用简化的评分算法,适用于广泛应用于自主研究和实践。